Treatment with Peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBeAg positive chronic hepatitis B harboring HBV gentoypes B or 'difficult-to-treat' genotype

被引：4

作者：

Cooksley, WGE

Lai, MY

Piratvisuth, T

Wang, YJ

Mahachai, V

Chao, YC

Tanwandee, T

Chutaputti, A

Chang, WY

Zahm, FE

Pluck, N

机构：

[1] Univ Queensland, Royal Brisbane Hosp, Herston 10764, Qld, Australia

[2] Natl Taiwan Univ, Taipei, Taiwan

[3] Songklanakarin Hosp, Songkhla, Thailand

[4] Taipei Vet Gen Hosp, Taipei, Taiwan

[5] Chulalongkorn Hosp, Bangkok, Thailand

[6] Tri Serv Gen Hosp, Taipei, Taiwan

[7] Siriraj Hosp, Bangkok, Thailand

[8] Pramongkutklao Hosp, Bangkok, Thailand

[9] Kaohsiung Univ Hosp, Kaohsiung, Taiwan

[10] F Hoffmann La Roche Ltd, Basel, Switzerland

[11] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England

来源：

关键词：

D O I：

10.1016/S0168-8278(03)80483-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：25 / 25

页数：1